Noblegen Biosciences Wins $182K Phase I SBIR Grant from NHGRI

Oct 11, 2011

Premium

Noblegen Biosciences has been awarded a $182,000 one-year phase I Small Business Innovation Research grant from the National Human Genome Research Institute to develop its "optipore" sequencing technology, the company disclosed this month.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

Hundreds of Thousands Wasted

The Associated Press reports that the US government wasted $341,000 on travel by former Health and Human Services Secretary Tom Price.

Down in the Comments

Women who post YouTube science videos get more critical comments and more comments about their appearance than male video hosts, the New York Times reports.

Mistrust Lingers

The Wall Street Journal writes that participating in genetic research brings up the specter of past research ethics lapses for some African Americans.

This Week in PLOS

In PLOS this week: sequences influencing yeast prion aggregation or degradation, dengue virus genetic variants affect transmission dynamics, and more.

Featured White Papers

Reliable Collection of High Quality Samples for Gut Microbiome Studies

Can Saliva Replace Blood for DNA Collection and Analysis?

Application of the Megaruptor for Shearing of Ultra-Long DNA Fragments in the Context of Long Read Sequencing using Third-Gen Sequencing Technologies

Megaruptor Genomic DNA Shearing for Large Insert Sequencing Library Preparation

Sep

17

Featured Webinar

Trends in Clinical NGS QC Management: Expert Insights to Ensure Quality Results for Your Lab

Today’s challenging clinical next-generation sequencing applications require a rigorous, comprehensive quality control management program to ensure confidence in results.

Main menu